# Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

> **NCT00777998** · PHASE2 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 221 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Auto-Allo Tandem SCT and maintenance therapy with Thalidomide/ DLI
- **PROCEDURE:** auto-auto Tandem stem cell transplantation and maintenance therapy with Thalidomide

## Key facts

- **NCT ID:** NCT00777998
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-14
- **Primary completion:** 2018-04-17
- **Final completion:** 2021-06
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777998, "Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00777998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*